139 related articles for article (PubMed ID: 35166183)
1. Simvastatin-loaded liposome nanoparticles treatment for uterine leiomyoma in a patient-derived xenograft mouse model: a pilot study.
El Sabeh M; Vincent KL; Afrin S; Motamedi M; Saada J; Yang J; Ozpolat B; Kilic GS; Borahay MA
J Obstet Gynaecol; 2022 Aug; 42(6):2139-2143. PubMed ID: 35166183
[TBL] [Abstract][Full Text] [Related]
2. Liposomal 2-Methoxyestradiol Nanoparticles for Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
Borahay MA; Vincent KL; Motamedi M; Tekedereli I; Salama SA; Ozpolat B; Kilic GS
Reprod Sci; 2021 Jan; 28(1):271-277. PubMed ID: 32632769
[TBL] [Abstract][Full Text] [Related]
3. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.
Borahay MA; Vincent K; Motamedi M; Sbrana E; Kilic GS; Al-Hendy A; Boehning D
Am J Obstet Gynecol; 2015 Aug; 213(2):196.e1-8. PubMed ID: 25840272
[TBL] [Abstract][Full Text] [Related]
4. PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
Enazy SA; Kirschen GW; Vincent K; Yang J; Saada J; Shah M; Oberhauser AF; Bujalowski PJ; Motamedi M; Salama SA; Kilic G; Rytting E; Borahay MA
J Pharm Sci; 2023 Sep; 112(9):2552-2560. PubMed ID: 37482124
[TBL] [Abstract][Full Text] [Related]
5. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
Koohestani F; Qiang W; MacNeill AL; Druschitz SA; Serna VA; Adur M; Kurita T; Nowak RA
Hum Reprod; 2016 Jul; 31(7):1540-51. PubMed ID: 27130615
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin induces degradation of the extracellular matrix in human leiomyomata: novel in vitro, in vivo, and patient level evidence of matrix metalloproteinase involvement.
Britten J; Roura-Monllor JA; Malik M; Moran S; DeAngelis A; Driggers P; Afrin S; Borahay M; Catherino WH
F S Sci; 2024 Feb; 5(1):80-91. PubMed ID: 38043603
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin reduces plasma membrane caveolae and caveolin-1 in uterine leiomyomas.
Afrin S; El Sabeh M; Miyashita-Ishiwata M; Charewycz N; Singh B; Borahay MA
Life Sci; 2022 Sep; 304():120708. PubMed ID: 35705139
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production.
Malik M; Britten J; Borahay M; Segars J; Catherino WH
Fertil Steril; 2018 Dec; 110(7):1398-1407.e1. PubMed ID: 30503138
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin Inhibits Wnt/β-Catenin Pathway in Uterine Leiomyoma.
El Sabeh M; Saha SK; Afrin S; Borahay MA
Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34614511
[TBL] [Abstract][Full Text] [Related]
10. Serum sestrin 2 levels in patients with uterine leiomyomas.
Kabakci M; Topbas Selcuki NF; Aydin Z; Bagci K; Kaya C; Yalcin Bahat P
J Obstet Gynaecol; 2022 Nov; 42(8):3616-3620. PubMed ID: 36346966
[TBL] [Abstract][Full Text] [Related]
11. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model.
Corachán A; Ferrero H; Escrig J; Monleon J; Faus A; Cervelló I; Pellicer A
Fertil Steril; 2020 Jan; 113(1):205-216.e4. PubMed ID: 31739978
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells.
Afrin S; Islam MS; Patzkowsky K; Malik M; Catherino WH; Segars JH; Borahay MA
Am J Obstet Gynecol; 2020 Nov; 223(5):733.e1-733.e14. PubMed ID: 32417359
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a novel mouse xenograft model of human uterine leiomyoma.
Suzuki Y; Ii M; Saito T; Terai Y; Tabata Y; Ohmichi M; Asahi M
Sci Rep; 2018 Jun; 8(1):8872. PubMed ID: 29891843
[TBL] [Abstract][Full Text] [Related]
15. Application of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease.
Fritsch M; Schmidt N; Gröticke I; Frisk AL; Keator CS; Koch M; Slayden OD
PLoS One; 2015; 10(11):e0142429. PubMed ID: 26588841
[TBL] [Abstract][Full Text] [Related]
16. The Role of Nanomedicine in Benign Gynecologic Disorders.
Lulseged BA; Ramaiyer MS; Michel R; Saad EE; Ozpolat B; Borahay MA
Molecules; 2024 May; 29(9):. PubMed ID: 38731586
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antiproliferative, proapoptotic, and antiangiogenic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of leiomyoma.
García-Pascual CM; Ferrero H; Juarez I; Martínez J; Villanueva A; Pozuelo-Rubio M; Soengas M; Tormo D; Simón C; Gómez R; Pellicer A
Fertil Steril; 2016 Feb; 105(2):529-38. PubMed ID: 26616441
[TBL] [Abstract][Full Text] [Related]
18. Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats.
Campos-Martorell M; Cano-Sarabia M; Simats A; Hernández-Guillamon M; Rosell A; Maspoch D; Montaner J
Int J Nanomedicine; 2016; 11():3035-48. PubMed ID: 27418824
[TBL] [Abstract][Full Text] [Related]
19. Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment.
Di Lieto A; De Rosa G; De Falco M; Iannotti F; Staibano S; Pollio F; Scaramellino M; Salvatore G
Hum Pathol; 2002 Feb; 33(2):220-4. PubMed ID: 11957148
[TBL] [Abstract][Full Text] [Related]
20. Anti-Uterine Fibroid Effect of Standardized Labisia Pumila Var. Alata Extracts In Vitro and in Human Uterine Fibroid Cancer Xenograft Model.
Zakaria N; Mohd KS; Ahmed Saeed MA; Ahmed Hassan LE; Shafaei A; Al-Suede FSR; Memon AH; Ismail Z
Asian Pac J Cancer Prev; 2020 Apr; 21(4):943-951. PubMed ID: 32334454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
